{"podcast":{"title":"Madison News Today | 2 Min News | The Daily News Now!","slug":"madison-news-today-2-min-news-the-daily-news-now-7577991","podcast_index_feed_id":7577991,"rss_url":"https://feeds.fastcast.ai/the-madison-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/the-madison-daily-news-now.jpg","author":"The Daily News Now!","episode_count":755,"summary":"Hosted by Corey with the Story, Madison News Today delivers fast, focused daily updates on the stories shaping Madison—from local news and business to culture, sports, and community developments. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local news to every city in the world and keeping communities connected. Madison News Today is your daily snapshot of what’s happening in your city. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-09-19T10:19:50.111492+00:00","page_url":"https://stenobird.com/podcast/madison-news-today-2-min-news-the-daily-news-now-7577991"},"episode":{"title":"First Drug for Alexander Disease Approved | Madison News","slug":"first-drug-for-alexander-disease-approved-madison-news","published_at":"2026-09-19T02:44:29+00:00","page_url":"https://stenobird.com/podcast/madison-news-today-2-min-news-the-daily-news-now-7577991/first-drug-for-alexander-disease-approved-madison-news","show_page_url":"https://stenobird.com/podcast/madison-news-today-2-min-news-the-daily-news-now-7577991","url":"https://sources.thednn.ai/cd748d93e2ce8559","audio_url":"https://api.fastcast.ai/audio/e06fae98-db1c-4a06-81f0-3b6768b1663b.mp3","summary":"Big breakthrough for rare disease patients: The FDA just approved Zanvastro, the first-ever drug to treat Alexander disease — a devastating neurological condition that affects movement, cognition, and vital functions. After 30 years of research, scientists finally targeted the root cause: a toxic buildup of GFAP protein. This new therapy stabilizes motor function, improves walking speed, and offers real hope where there was once only symptom management. Administered via spinal injection every three months, Zanvastro marks a historic leap forward — turning lab discoveries into life-changing treatment for families waiting decades for answers. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Sources: https://madison.com/news/community/article_569e6397-adf0-5a79-baff-bfe9320ee699.html More coverage & latest updates: https://sources.thednn.ai/cd748d93e2ce8559 Report issues to feedback@thednn.ai.","meta_description":"Big breakthrough for rare disease patients: The FDA just approved Zanvastro, the first-ever drug to treat Alexander disease — a devastating neurological c…","key_points":[],"chapters":[],"topics":[],"duration_seconds":117,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/madison-news-today-2-min-news-the-daily-news-now-7577991/episodes/first-drug-for-alexander-disease-approved-madison-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/madison-news-today-2-min-news-the-daily-news-now-7577991/first-drug-for-alexander-disease-approved-madison-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}